mutations, immunology, culture
The Benefits of Trepidation
The Benefits of Trepidation
Abigail Marsh | Nov 1, 2017
While wiping fear from our brains may seem attractive, the emotion is an essential part of our behavioral repertoire.
2017 Life Science Salary Survey
2017 Life Science Salary Survey
Aggie Mika | Nov 1, 2017
Industry professionals make more than academic researchers, but for professors, it may not be about the money.
Salary Survey: By the Numbers
Salary Survey: By the Numbers
Aggie Mika | Oct 31, 2017
An overview of this year's results in graphical form
Base Editing Now Able to Convert Adenine-Thymine to Guanine-Cytosine
Base Editing Now Able to Convert Adenine-Thymine to Guanine-Cytosine
Catherine Offord | Oct 25, 2017
With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.
FDA Approves Second CAR T-Cell Therapy
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 
Compound Found in Red Wine Boosts Immune Cell Function
Compound Found in Red Wine Boosts Immune Cell Function
Catherine Offord | Oct 16, 2017
At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 
Cancers Relapse by Feeding Off Immune Signals
Cancers Relapse by Feeding Off Immune Signals
Shawna Williams | Oct 16, 2017
In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.
On Science and Hip Hop: Q&A with the Wu-Tang Clan’s GZA
On Science and Hip Hop: Q&A with the Wu-Tang Clan’s GZA
Aggie Mika | Oct 13, 2017
The artist discusses music as a means to get kids excited about science, and the inspiration he took from astrophysics and polar bears.
Advisors to FDA Recommend Approval of Gene Therapy for Blindness
Advisors to FDA Recommend Approval of Gene Therapy for Blindness
Jef Akst | Oct 12, 2017
Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.
U.S. Withdraws from UNESCO
U.S. Withdraws from UNESCO
Catherine Offord | Oct 12, 2017
The decision to leave the United Nations’ educational, scientific, and cultural agency was spurred by what American officials say is the organization’s anti-Israel bias and lack of commitment to reform.